Lv6
2528 积分 2021-04-01 加入
How I treat HLH-like toxicities after immune effector cell therapy
29天前
已关闭
The evolving landscape of complement therapeutics in rheumatology
1个月前
已完结
Real-world Use of Canakinumab in Familial Mediterranean Fever and Other Autoinflammatory Disorders
2个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
3个月前
已关闭
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
4个月前
已完结
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
4个月前
已完结
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
4个月前
已完结
Targeting NK cell CLEC12B enhances cancer immunotherapy
4个月前
已关闭
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
4个月前
已完结
皖公网安备34019202002308
